Effects Of Alpha-lipoic Acid Supplementation In Peripheral Arterial Disease: A Pilot Study

Effect Decrease
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 28
Sex Both Genders
Age Range 65+
Body Types Overweight, Average
Notes for this study:
3 months of ALA supplementation in a population of peripheral arterial disease with 600mg ALA daily.

Reduction of subjective pain and a beneficial trend of blood health and claudation were noted. Oxidative stress did not differ between groups, nor did C-reactive protein.